Universe Pharmaceuticals Inc (UPC) — Cash Flow Reinvestment Rate
Universe Pharmaceuticals Inc (UPC) has a Cash Flow Reinvestment Rate of 0.04x as of March 2025, reinvesting $96.78K (capex $96.78K ) from operating cash flow of $2.56 Million. See Universe Pharmaceuticals Inc (UPC) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Universe Pharmaceuticals Inc Cash Flow Reinvestment Rate (2018–2023)
Historical reinvestment intensity for Universe Pharmaceuticals Inc across 4 annual periods. For the full cash flow conversion analysis, see UPC cash flow conversion.
Annual Cash Flow Reinvestment Rate for Universe Pharmaceuticals Inc (2018–2023)
Year-by-year capital reinvestment analysis for Universe Pharmaceuticals Inc. See Universe Pharmaceuticals Inc (UPC) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.08x | $88.34K | $1.12 Million | $44.17K | ▲ +365.6% |
| 2020 | 0.02x | $103.60K | $6.12 Million | $51.80K | ▲ +29.8% |
| 2019 | 0.01x | $172.36K | $13.20 Million | $86.32K | ▼ -80.0% |
| 2018 | 0.07x | $290.19K | $4.46 Million | $145.09K | — |